Reza Azizian, Ph.D.

Specializing in phage therapy, anti-biofilm dynamics & POCT (RPA). ESCMID member. Seeking a postdoc in Europe.

[Reza Azizian, Ph.D. @RzaAzi]

🧠 Understanding Meningitis: From bacterial & viral etiologies to its emerging link with #COVID19 neurological complications.
Rapid pathogen identification saves lives.

Read the full study here 👇

https://t.co/msKvsS0zy7

#Meningitis #Neurology #Microbiology

[Reza Azizian, Ph.D. @RzaAzi]

🦠 *H. pylori* pathogenesis reflects a complex host–pathogen interaction.

Urease may promote adhesion and trigger caspase-3–mediated apoptosis, while **HLA-DQA1 variants** may influence susceptibility or resistance.

#HPylori #HLA #Microbiology

https://t.co/2n5TXPc3wU

[Reza Azizian, Ph.D. @RzaAzi]

The #phageome changes your life and health. #Phageome_dysbiosis can lead to #infections or #autoimmune_diseases.

https://t.co/SQhnfymcZc

[Reza Azizian, Ph.D. @RzaAzi]

Honored our paper on using sewage to find phages against Pseudomonas aeruginosa is featured by Norgen Biotek! Reliable phage DNA isolation is vital for tackling AMR.

Full paper: https://t.co/dMCYZHf90z

#PhageTherapy #AMR #Microbiology

[Reza Azizian, Ph.D. @RzaAzi]

Thrilled #NEB featured our research! We developed a rapid, sensitive #RPA method to detect #P_aeruginosa . Huge shout out to NEB, their Bsu DNA Polymerase was the core of our enzyme mix. Reliable reagents are essential for rapid diagnostics!

https://t.co/amBZxzxrlJ

[Reza Azizian, Ph.D. @RzaAzi]

Could our resident #phageome prevent hospital biofilms?

Oral and gut phages control bacteria, disrupt EPS, and reduce #biofilm formation. Combining phageome #metagenomics with targeted phage therapy could help fight AMR and device-associated infections.

https://t.co/WRLA8tQRQj

[Reza Azizian, Ph.D. @RzaAzi]

What if viruses are the missing piece in precision medicine?
Meet the #PHAGEOME: the viruses that infect your bacteria. Your daily habits shape them, and in turn, they regulate your #microbiome, impact drug resistance & control ecosystem stability.

https://t.co/sf0Cr1w7dt

[Reza Azizian, Ph.D. @RzaAzi]

Why wait 48+ hrs to diagnose a sick child?
Pediatric diagnostics are moving to the bedside, slashing wait times to <20 mins with POCT!
Accurate, bedside molecular results Stops antibiotic overuse to fight AMR
Quicker peace of mind for parents
https://t.co/OcLw2bzwPD

#POCT

[Reza Azizian, Ph.D. @RzaAzi]

Celiac disease isn't just about HLA-DQ2/DQ8 genetics — gut microbiota (Prevotella, DPP-4) plays a key role in risk & offers new therapeutic targets beyond gluten-free diets.

📄 https://t.co/jlP8zevSuj…
https://t.co/QoAIBiPKep
#CeliacDisease #Microbiome #Immunology

[Reza Azizian, Ph.D. @RzaAzi]

#Pseudomonas_aeruginosa phage isolated from university sewage reduced biofilm OD₄₉₂ from 1.6 to 1.3 at 10⁻² dilution in microplate assays, with cross-activity against #P_putida, #E_coli and #A_baumannii biofilms. Optimum titre matters most.

https://t.co/5NZ9UoYBhG

[Reza Azizian, Ph.D. @RzaAzi]

Obese H. pylori-positive patients screened for virulence genes via PCR (vacA 100%, cagE 77% and cagA 72.5%). s1m2 was the dominant vacA genotype (79%). vacA, iceA1 and oipA were significantly linked to higher GI disorder risk.
https://t.co/46leAn2R5s
#Hpylori #GICancer #Obesity

[Reza Azizian, Ph.D. @RzaAzi]

Probiotics and Metagenomics Role on the Oral Health" now published in Microbial Metagenomics in Effluent Treatment Plant.

🔗 https://t.co/G7KHUsq0Ty

#Microbiome #Probiotics #OralHealth #Metagenomics

[Reza Azizian, Ph.D. @RzaAzi]

Pediatric bacterial respiratory infections require rapid diagnosis. Multiplex #PCR and #POCT enable fast, accurate pathogen detection, guiding targeted therapy, improving care, and supporting antimicrobial stewardship.

#Diagnostics #Pediatrics

https://t.co/OcLw2bzwPD

[Reza Azizian, Ph.D. @RzaAzi]

Antibiotic misuse accelerates the rise of #multidrug_resistant bacteria. #Lytic_phages infect bacteria, replicate, and burst them open. Unlike antibiotics, phages can eliminate #MDR bacteria without being inactivated by bacterial drug-resistance enzymes.

https://t.co/sKgoKb1Zw1

[Reza Azizian, Ph.D. @RzaAzi]

Phage therapy pipeline is crowded. Beyond #BiomX: #Armata (CF, Staph bacteremia), #Pherecydes (bone/joint infections), #Intralytix (C. diff, Salmonella), #Technophage (diabetic foot), #NexaBiome (delivery tech). Multiple shots on goal exactly what AMR needs. #PhageTherapy

[Reza Azizian, Ph.D. @RzaAzi]

Back to Phage therapy: 60trials in 2025. CRISPR-enhanced phages hitting UTIs, nebulized versions for cystic fibrosis, Big Pharma investing. Not a magic bullet yet, but moving from last-resort to mainstream. Century-old cure is finally getting its clinical moment.
#PhageTherapy

[Reza Azizian, Ph.D. @RzaAzi]

Pawel Tulinski  
BiomX (PHGE) has just launched a new phage therapy trial and it got me digging deeper. Here’s the latest MicroBioBridge Consulting summary of where human phage therapy(2025) , trials, history, and what’s still missing for EMA/FDA approval.
#MicroBioBridge

[Reza Azizian, Ph.D. @RzaAzi]

Non-pathogenic E. coli strains (K-12, MG1655, BL21, ST155) are revolutionizing phage manufacturing! 🦠 Safe BSL-1 hosts now produce phages targeting Pseudomonas, Klebsiella & Salmonella — no virulence genes, GMP-compliant, scalable.
🧬 #Phage_Therapy
#AMR

[Reza Azizian, Ph.D. @RzaAzi]

#تصویرنمایه‌جدید

[Reza Azizian, Ph.D. @RzaAzi]

I am seeking a postdoctoral position in Molecular POCT, phage therapy, and infectious diseases in Europe. I would greatly appreciate any updated information on available positions.
#Postdoctoral_Position #Molecular_POCT #Phage_Therapy #Infectious_Diseases #Europe"